{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:04:07Z","timestamp":1789513447922,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clon.2026.104211","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:09:39Z","timestamp":1781222979000},"page":"104211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The Relevance of Cancer-Type-Specific Scenarios in Predicting Primary Radiotherapy Use in Nonmetastatic Cancer Patients in the Netherlands Towards 2032"],"prefix":"10.1016","volume":"56","author":[{"given":"H.","family":"Struikmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-9786","authenticated-orcid":false,"given":"J.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Bauhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.W.M.M.","family":"Bloemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.P.","family":"Dirkx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.H.","family":"Doornaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-2919","authenticated-orcid":false,"given":"A.W.H.","family":"Minken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.C.","family":"van der Sangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-824X","authenticated-orcid":false,"given":"S.","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-007X","authenticated-orcid":false,"given":"M.J.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2026.104211_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0167-8140(03)00025-2","article-title":"Infrastructure of radiotherapy in the Netherlands: evaluation of prognoses and introduction of a new model for determining the needs","volume":"66","author":"Slotman","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2013.02.006","article-title":"Planning of radiotherapy capacity and productivity","volume":"106","author":"Slotman","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lungcan.2021.03.013","article-title":"Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008 to 2018: A nationwide population-based study from the Netherlands","volume":"155","author":"Evers","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2026.104211_bib4","article-title":"Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands-A Nationwide Overview From 2008 Until 2022","volume":"38","author":"Evers","year":"2025","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"10.1016\/j.clon.2026.104211_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clon.2024.08.010","article-title":"Radiotherapy Trends and Variations in Invasive Non-metastatic Breast Cancer Treatment in the Netherlands: A Nationwide Overview From 2008 to 2019","volume":"36","author":"Evers","year":"2024","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"10.1016\/j.clon.2026.104211_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.radonc.2022.10.028","article-title":"Trends and variation in the use of radiotherapy in non-metastatic prostate cancer: A 12-year nationwide overview from the Netherlands","volume":"177","author":"Evers","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clon.2024.01.013","article-title":"Trends and Variation in the Use of Radiotherapy in Non-metastatic Rectal Cancer: a 14-year Nationwide Overview from the Netherlands","volume":"36","author":"Verrijssen","year":"2024","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"10.1016\/j.clon.2026.104211_bib8","series-title":"Understanding random forest","author":"Yiu","year":"2019"},{"key":"10.1016\/j.clon.2026.104211_bib9","series-title":"Understand random forest algorithms with examples","author":"Sruthi","year":"2023"},{"key":"10.1016\/j.clon.2026.104211_bib10","series-title":"Kanker in Nederland - trends & prognoses tot en met 2032","author":"Praagman","year":"2022"},{"issue":"Suppl 1","key":"10.1016\/j.clon.2026.104211_bib11","first-page":"S1","article-title":"Prediction of cancer incidence in the Nordic countries up to the year 2020","volume":"11","author":"Moller","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.clon.2026.104211_bib12","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/sim.1481","article-title":"Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches","volume":"22","author":"Moller","year":"2003","journal-title":"Stat Med"},{"key":"10.1016\/j.clon.2026.104211_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/sim.4780060406","article-title":"Models for temporal variation in cancer rates. II: Age-period-cohort models","volume":"6","author":"Clayton","year":"1987","journal-title":"Stat Med"},{"key":"10.1016\/j.clon.2026.104211_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0049124111415367","article-title":"Constrained Estimators and Age-Period-Cohort Models","volume":"40","author":"O'Brien","year":"2011","journal-title":"Sociological Methods Res"},{"key":"10.1016\/j.clon.2026.104211_bib15","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s13524-019-00801-6","article-title":"Bounding Analyses of Age-Period-Cohort Effects","volume":"56","author":"Fosse","year":"2019","journal-title":"Demography"},{"key":"10.1016\/j.clon.2026.104211_bib16","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1080\/00949655.2020.1783262","article-title":"Approximate leave-future-out cross-validation for Bayesian time series models","volume":"90","author":"B\u00fcrkner","year":"2020","journal-title":"J Stat Comput Simulation"},{"key":"10.1016\/j.clon.2026.104211_bib17","series-title":"ENCR-IACR 2023","article-title":"Improved forecasting of cancer incidence using leave out validation","author":"Bijlsma","year":"2023"},{"key":"10.1016\/j.clon.2026.104211_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2023.09.352","article-title":"P1.14-04 European Lung Cancer Screening Implementation: 4-IN-THE-LUNG-RUN trial","volume":"18","author":"van der Aalst","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2026.104211_bib20","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib21","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jgo.2021.05.005","article-title":"Age-related treatment patterns for stage I NSCLC in three European countries","volume":"12","author":"Damhuis","year":"2021","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/OP.22.00475","article-title":"Stereotactic Body Radiotherapy for the Management of Early-Stage Non-Small-Cell Lung Cancer: A Clinical Overview","volume":"19","author":"Buchberger","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.clon.2026.104211_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clon.2026.104211_bib24","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2026.104211_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2026.104211_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.radonc.2011.05.012","article-title":"An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer from 1997 till 2008: a population-based study in the Netherlands","volume":"100","author":"Struikmans","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/tbj.13376","article-title":"An actualised population-based study on the use of radiotherapy in breast cancer patients in the Netherlands","volume":"25","author":"Schreuder","year":"2019","journal-title":"Breast J"},{"key":"10.1016\/j.clon.2026.104211_bib28","series-title":"Tailored treatment in Older Patients TOP-1: omission of radiotherapy in elderly patients with low risk breast cancer","year":"2025"},{"key":"10.1016\/j.clon.2026.104211_bib29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clon.2018.11.033","article-title":"Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors","volume":"31","author":"Schreuder","year":"2019","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"10.1016\/j.clon.2026.104211_bib30","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib31","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ijrobp.2023.08.034","article-title":"Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK\/06\/003)","volume":"117","author":"Kirby","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104211_bib32","article-title":"Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy","volume":"49","author":"Gunster","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clon.2021.04.016","article-title":"Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation","volume":"33","author":"Brunt","year":"2021","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"10.1016\/j.clon.2026.104211_bib34","article-title":"Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands","volume":"47","author":"Eijkelboom","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14599","article-title":"Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting","volume":"7","author":"Ventimiglia","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clon.2026.104211_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.euo.2022.07.004","article-title":"Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression","volume":"5","author":"Baboudjian","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00066-023-02192-5","article-title":"Six-year outcomes of robot-assisted radical prostatectomy versus volumetric modulated arc therapy for localized prostate cancer: A propensity score-matched analysis","volume":"200","author":"Noda","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clon.2026.104211_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2026.104211_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(20)30581-7","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial","volume":"22","author":"Fransson","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib40","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abd66d","article-title":"Proof-of-concept delivery of intensity modulated arc therapy on the Elekta Unity 1.5 T MR-linac","volume":"66","author":"Kontaxis","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2026.104211_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2468-1253(21)00368-X","article-title":"Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study","volume":"7","author":"Breekveldt","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clon.2026.104211_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/a-1811-7025","article-title":"Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022","volume":"54","author":"Pimentel-Nunes","year":"2022","journal-title":"Endoscopy"},{"key":"10.1016\/j.clon.2026.104211_bib43","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.cgh.2020.05.060","article-title":"Long-term Outcomes of Primary Endoscopic Resection vs Surgery for T1 Colorectal Cancer: A Systematic Review and Meta-analysis","volume":"18","author":"Yeh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clon.2026.104211_bib44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","article-title":"Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Benson","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clon.2026.104211_bib45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00066-017-1240-8","article-title":"OGRO survey on radiotherapy capacity in Austria : Status quo and estimation of future demands","volume":"194","author":"Zurl","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clon.2026.104211_bib46","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ijrobp.2023.07.026","article-title":"Supply and Demand for Radiation Oncologists in Canada: Workforce Planning Projections From 2020 to 2040","volume":"119","author":"Loewen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104211_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijrobp.2016.02.064","article-title":"Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025","volume":"96","author":"Pan","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104211_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012","volume":"112","author":"Barton","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2022.10.002","article-title":"Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review","volume":"14","author":"Mackenzie","year":"2023","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.clon.2026.104211_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clon.2021.12.007","article-title":"Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences","volume":"34","author":"Boersma","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2026.104211_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526001822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526001822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:41:27Z","timestamp":1789512087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S0936655526001822"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104211","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Relevance of Cancer-Type-Specific Scenarios in Predicting Primary Radiotherapy Use in Nonmetastatic Cancer Patients in the Netherlands Towards 2032","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104211"}}